Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Wood Group requests third extension to Sidara takeover deadline as talks continue

(Sharecast News) - Wood Group has requested another extension to the takeover deadline, giving Sidara an extra month to either announce a firm intention to make an offer or walk away. The so-called 'put up or shut up' deadline, which now stands at 28 July, has already been extended two times since Sidara's initial proposal was made public in mid-April. The current deadline was due to expire on Monday.

"The board of Wood is continuing to work with Sidara in relation to the pre-conditions to the possible offer set out in that announcement," the oilfield engineering and consulting company said in a statement.

Earlier this month, media reports suggested that Wood wanted the proposed £242m takeover done before the end of June, when a waiver of its debt covenants is scheduled to expire.

The 35p-per-share offer is just a fraction of the 230p price tag proposed by Sidari in May 2024, before revelations about corporate governance and questionable financial results tanked the stock.

Wood said on Monday that the two sides are "engag[ing] constructively" with Wood's lenders and noteholders in relation to debt modifications and Sidara liquidity arrangements. Meanwhile, Wood is still working with its auditor regarding the publication of its financial results for 2024.

"There continues to be no certainty that an offer will be made by Sidara even if the pre-conditions to the Possible Offer are satisfied or waived. This announcement is being made with the consent of Sidara," Wood said.

The company as of last week is currently under investigation by the Financial Conduct Authority regarding the period from 1 January 2023 to 7 November 2024.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.